Gateway Investment Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Gateway Investment Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-12,181	Closed	-$91K	–	677
2014 Q3	$91K	Hold	12,181	–	–	﹤0.01%	667
2014 Q2	$118K	Hold	12,181	–	–	﹤0.01%	670
2014 Q1	$101K	Hold	12,181	–	–	﹤0.01%	662
2013 Q4	$103K	Hold	12,181	–	–	﹤0.01%	663
2013 Q3	$97K	Hold	12,181	–	–	﹤0.01%	663
2013 Q2	$94K	Buy	+12,181	New	+$95K	﹤0.01%	658

Other funds holding PDLI

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gateway Investment Advisers's PDLI Position: Q4 2014 in Review

Gateway Investment Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 12,181 shares — an estimated $91K sold.

Gateway Investment Advisers first reported a position in PDLI in Q2 2013 and held it in 6 quarters. The position peaked at $118K in Q2 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

Gateway Investment Advisers reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
Gateway Investment Advisers sold 12,181 PDL BioPharma, Inc. shares in Q4 2014, an estimated $91K.
Gateway Investment Advisers first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 6 quarters.
Gateway Investment Advisers's PDL BioPharma, Inc. position peaked at $118K in Q2 2014.
223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on Gateway Investment Advisers's 13F filing for Q4 2014, filed 28 Jan 2015.